Patents by Inventor Matthias Luz

Matthias Luz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10065021
    Abstract: A catheter for delivering an agent to targeted tissue of a mammalian body including a first elongate tubular member having a proximal opening and a distal end wall. A second elongate tubular member having a portion extends through first elongate tubular member and has a distal end extending beyond the end wall. The first and second tubular members form an annular cavity within the first tubular member. A stiffening member has at least a portion disposed within the annular cavity for facilitating accurate placement of the distal end relative to the targeted tissue in the mammalian body and is removeable from the annular cavity after such placement without removal of the second elongate tubular member from the mammalian body. A method is provided.
    Type: Grant
    Filed: May 16, 2008
    Date of Patent: September 4, 2018
    Assignee: MEDGENESIS THERAPEUTIX, INC.
    Inventors: Amy Grahn, Matthias Luz
  • Patent number: 9295735
    Abstract: Convection-enhanced delivery (CED) is used as a method to deliver a direct infusion of therapeutic agents to the central nervous center thus circumventing the blood-blood barrier. A non-PEGylated liposomal composition comprising at least one saturated neutral phospholipid and at least one saturated anionic phospholipid and a therapeutic or diagnostic agent encapsulated therein is used to overcome toxicity associated with high peak drug concentration delivered locally CED as well as to increase tissue distribution volume for an improved sustained drug release. In one embodiment, the liposome composition comprises a molar ratio of DSPC:DSPG:CHOL of 7:2:1 and the therapeutic or diagnostic agent is selected from topotecan, conotoxin, gadodiamide or rhodamine, and is used in the treatment of epilepsy.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: March 29, 2016
    Assignee: MEDGENESIS THERAPEUTIX, INC.
    Inventors: Thomas Redelmeier, Matthias Luz
  • Publication number: 20110274625
    Abstract: Convection-enhanced delivery (CED) is used as a method to deliver a direct infusion of therapeutic agents to the central nervous centre thus circumventing the blood-blood barrier. A non-PEGylated liposomal composition comprising at least one saturated neutral phospholipid and at least one saturated anionic phospholipid and a therapeutic or diagnostic agent encapsulated therein is used to overcome toxicity associated with high peak drug concentration delivered locally CED as well as to increase tissue distribution volume for an improved sustained drug release.
    Type: Application
    Filed: November 23, 2009
    Publication date: November 10, 2011
    Applicant: MedGenesis Therapeutix ,Inc.
    Inventors: Thomas Redelmeier, Matthias Luz
  • Publication number: 20100217228
    Abstract: A catheter for delivering an agent to targeted tissue of a mammalian body including a first elongate tubular member having a proximal opening and a distal end wall. A second elongate tubular member having a portion extends through first elongate tubular member and has a distal end extending beyond the end wall. The first and second tubular members form an annular cavity within the first tubular member. A stiffening member has at least a portion disposed within the annular cavity for facilitating accurate placement of the distal end relative to the targeted tissue in the mammalian body and is removeable from the annular cavity after such placement without removal of the second elongate tubular member from the mammalian body. A method is provided.
    Type: Application
    Filed: May 16, 2008
    Publication date: August 26, 2010
    Applicant: MedGenesis Therapeutix, Inc.
    Inventors: Amy Grahn, Matthias Luz